Reference no: EM131463741

Endocrine, Reproductive, and Cardiovascular Drugs

Complete the following and submit your answers.

Chapter 23, page 470, Case Study B- Antidiabetic Agents and page 471, questions 1 through 10.

Chapter 25, page 494, questions 1 through 10.

Case Study B - Antidiabetic Drugs

1. The physician starts him on glyburide, a sulfonylurea medication. He explains to Marcus that sulfonylureas work by:

2. The physician explains to Marcus that one of the side effects of a sulfonylurea medication is:

3. Prior to prescribing the medication, the physician reviews Marcus's medical history. This is because sulfonylureas must be used with extreme caution in individual's who:

4. The physician cautions Marcus to call him prior to taking any other medication because of possible interactions. Which drug can potentiate the hypoglycemic effect of a sulfonylurea?

5. What drug causes an interaction with sulfonylureas, resulting in antagonistic action in which a larger dose may be required?

Antidiabetic Agents and page 471, questions 1 through 10.

1. Glucophage - Oral antidiabetic agent

2. prednisone - Corticosteroid

3. Humulin R - Insulin: short acting

4. Synthroid - Thyroid agent

5. Avandia - Oral antidiabetic agent

6. Tapazole - Antithyroid

7. Isophane - Insulin: intermediate acting

8. Prandin - Oral antidiabetic agent

9. Lantus - Insulin: long acting

10. Humalog - Insulin: rapid acting

Chapter 25, page 494 (actually pg. 541), questions 1 through 10

1. isosorbide - Angina

2. Zetia - Elevated cholesterol

3. Lovenox - Pulmonary emboli

4. Cardizem - Hypertension

5. Zocor - Elevated cholesterol

6. Plavix - Stroke prevention (platelet inhibitor)

7. Crestor - Elevated cholesterol

8. hydralazine - Hypertension

9. quinidine - Cardiac arrhythmia

10. procainamide - Cardiac arrhythmia